US Patent 8354534 Selective opioid compounds
Patent 8354534 was granted and assigned to Alkermes (company) on January, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+144 characters)
Article
Patent abstract
The present invention relates to compounds of Formula I or II, or pharmaceutically acceptable salts, esters, or prodrugs thereof:
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Daniel Deaver0
Derrick Arnelle0
Mark Todtenkopf0
Reginald L. Dean, III0
Edits on 26 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08354534 Selective opioid compounds US Patent 8354534 Selective opioid compounds
Infobox
Patent Number
083545340
Patent Number
83545340
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083545340
Date of Patent
January 15, 2013
0Patent Application Number
123713340
Date Filed
February 13, 2009
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08354534 Selective opioid compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08354534
Date of patent
January 15, 2013
Patent application number
12371334
Date Filed
February 13, 2009
Patent primary examiner
Find more entities like US Patent 8354534 Selective opioid compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
